First-in-Human Evaluation of the Safety and Immunogenicity of a Recombinant Adenovirus Serotype 26 HIV-1 Env Vaccine (IPCAVD 001)Lindsey R. Baden, Dan H. Barouch, Kathleen H. Krause et al.|The Journal of Infectious Diseases|2012Cited by 168
Safety and Immunogenicity of Modified Vaccinia Ankara in Hematopoietic Stem Cell Transplant Recipients: A Randomized, Controlled TrialStephen R. Walsh, Lindsey R. Baden, Marissa B. Wilck et al.|The Journal of Infectious Diseases|2013Cited by 76